New HAE drug switch study aims for safer monthly shots
NCT ID NCT06806657
First seen Mar 13, 2026 · Last updated May 23, 2026 · Updated 12 times
Summary
This study checks if it's safe for people aged 12 and older with hereditary angioedema (HAE) to switch from their current preventive treatment to a new monthly injection called garadacimab. About 18 participants will receive garadacimab for around 3 months, and researchers will monitor for side effects. The goal is to see if this switch is well-tolerated and safe.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEREDITARY ANGIOEDEMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Allergy and Asthma Clinic of Northwest Arkansas
Bentonville, Arkansas, 72712, United States
-
Bernstein Clinical Research Center, LLC
Cincinnati, Ohio, 45236, United States
-
Chronicle Bio
West Valley City, Utah, 84119, United States
-
Clinique Spécialisée en Allergie de la Capitale
Québec, G1V 4W2, Canada
-
Donald Levy M.D.
Orange, California, 92868, United States
-
HZRM Hämophilie Zentrum Rhein Main GmbH
Frankfurt, 60596, Germany
-
Hautklinik und Poliklinik der Universitätsklinik Mainz
Mainz, 55131, Germany
-
McMaster University-Hamilton
Hamilton, Ontario, ON L8N3Z5, Canada
-
Montreal Clinical Research Institute
Montreal, Quebec, QC H2W 1R7, Canada
-
Raffi Tachdjian MD, Inc.
Santa Monica, California, 90404, United States
-
Research Solutions of Arizona
Litchfield Park, Arizona, 85340, United States
Conditions
Explore the condition pages connected to this study.